Sun, January 26, 2025
[ Sun, Jan 26th ]: MSN
Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
Sat, January 25, 2025
[ Sat, Jan 25th ]: dailyinvestor
Superinvestor Bill Ackman's journey to $13 billion
[ Sat, Jan 25th ]: MSN
Is AMETEK, Inc. (AME) Among Billionaire Mario Gabelli's Top Stock Picks?
[ Sat, Jan 25th ]: MSN
Billionaire Ray Dalio offers fresh tips on how to be a better investor
[ Sat, Jan 25th ]: MSN
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
[ Sat, Jan 25th ]: MSN
Global Financial Trends to Watch in 2025
[ Sat, Jan 25th ]: MSN
Prediction: This Stock Will be the Biggest Winner of the U.S.' New $500 Billion AI Project.
[ Sat, Jan 25th ]: MSN
Looking to Build a $1 Million Portfolio? 3 Vanguard ETFs to Buy in 2025 and Hold Forever
[ Sat, Jan 25th ]: MSN
Is United Parcel Service (UPS) the Best Ethical Company to Invest in According to Reddit?
[ Sat, Jan 25th ]: MSN
The Smartest Semiconductor Stocks to Buy With $1,000 Right Now
[ Sat, Jan 25th ]: MSN
3 Growth ETFs to Buy With $2,000 and Hold Forever
[ Sat, Jan 25th ]: MSN
Is Textron (TXT) Among Billionaire Mario Gabelli's Top Stock Picks?
[ Sat, Jan 25th ]: Kiplinger
Stock Market Today: Stocks Slip as Inflation Worries Rise
[ Sat, Jan 25th ]: MSN
Why Waste Management, Inc. (WM) Is One of the Bes .. hical Companies to Invest in According to Reddit?
[ Sat, Jan 25th ]: MSN
Why You Shouldn't Hesitate to Buy These Top Stocks in 2025
[ Sat, Jan 25th ]: MSN
The Top Canadian Stocks to Buy Right Away With $35,000
Fri, January 24, 2025
[ Fri, Jan 24th ]: MSN
Investing $10,000 in These 2 Stocks Could Make You $100,000 Richer
[ Fri, Jan 24th ]: MSN
GE's SWOT analysis: aerospace giant's stock soars on aftermarket growth
[ Fri, Jan 24th ]: MSN
1 Delectable Dividend Stock Down 11% to Buy Now and Hold
[ Fri, Jan 24th ]: MSN
Walmart CEO Doug McMillon sells $2.7 million in company stock
[ Fri, Jan 24th ]: Investing
FTSE 100 retreats from record to fall; Storm Eowyn batters Ireland and Scotland
[ Fri, Jan 24th ]: MSN
Cantor initiates coverage on Space sector stocks
[ Fri, Jan 24th ]: MSN
Invest $20,000 in 2 TSX Stocks for $3,442.44 in Passive Income
[ Fri, Jan 24th ]: MSN
Morgan Stanley sees defensive plays as key in challenging energy market
[ Fri, Jan 24th ]: Investopedia
How to Invest in Uncertain Times
[ Fri, Jan 24th ]: FXStreet
Trump trade back in vogue - Societe Generale
[ Fri, Jan 24th ]: Morningstar
Why Inflation Still Poses a Risk to Stocks and Bonds in 2025
[ Fri, Jan 24th ]: MSN
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
[ Fri, Jan 24th ]: Kiplinger
Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy
[ Fri, Jan 24th ]: MarketWatch
Will inflation pick back up and hurt stocks? The .. r depends on if you ask a Republican or Democrat.
[ Fri, Jan 24th ]: MSN
Why The Coca-Cola Company (KO) Is One of the Best .. hical Companies to Invest in According to Reddit?
[ Fri, Jan 24th ]: MSN
Futures dip as caution over Trump sets in; dollar down
[ Fri, Jan 24th ]: MSN
Bitcoin is on fire. If you're new to crypto, read our tips before you invest
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of DAN at $15 .. 1, after crossing above the $14.941 Trigger Price
[ Fri, Jan 24th ]: MSN
Foreigners are chasing U.S. stocks. Historically, that's a bad sign.
[ Fri, Jan 24th ]: MSN
2 Technology Stocks That Could Help Set You Up for Life
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of WSTG at $1 .. 1, after crossing above the $25.159 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of WISH at $6 .. 99, after crossing above the $5.596 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of VVI at $38 .. 7, after crossing above the $30.358 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of VEC at $53 .. 5, after crossing above the $45.917 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of UEPS at $5.15, after crossing above the $4.22 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of UCBI at $3 .. 8, after crossing above the $29.066 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of TRVG at $2.7, after crossing above the $2.674 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of TNP at $17 .. 8, after crossing above the $12.111 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of TMST at $1 .. 74, after crossing above the $14.18 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of TBK at $78 .. 8, after crossing above the $63.767 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of SYNL at $1 .. 9, after crossing above the $10.132 Trigger Price
[ Fri, Jan 24th ]: WOPRAI
Short squeeze is starting in shares of STRC at $9 .. 19, after crossing above the $2.015 Trigger Price

Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. drug-data-and-analysts-say-it-s-still-a-buy.html
  Print publication without navigation Published in Stocks and Investing on by Kiplinger
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.
The article from Kiplinger discusses the investment potential of Novo Nordisk (NVO), a Danish pharmaceutical company, focusing on its recent developments in weight loss drugs. Novo Nordisk has shown promising results with its drug semaglutide, marketed as Wegovy for weight loss, which has led to significant stock price increases. The company's shares have risen by 45% in the past year, outperforming the S&P 500. Analyst evaluations, including from Barclays, have given Novo Nordisk an "overweight" rating, citing the company's strong market position in diabetes and obesity treatments. The article highlights the potential for further growth due to the expanding market for obesity treatments, with Wegovy's sales expected to grow as it gains more market share. However, it also notes concerns about supply constraints and competition from other pharmaceutical companies like Eli Lilly. Overall, the consensus seems to lean towards a buy rating for Novo Nordisk stock, driven by its innovative treatments and robust pipeline in metabolic disorders.

Read the Full Kiplinger Article at:
[ https://www.kiplinger.com/investing/stocks/novo-nordisk-nvo-stock-weight-loss-drug-data-buy-rating ]